ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

Obama Signs Bill Giving FDA Authority Over Tobacco Products

June 26, 2009

In Brief: Gertrude Elion, Nobel Laureae Whose Work Led To New Drugs For Cancer, Dead at 81

February 26, 1999

Garb’s Fight Now A Personal One

March 20, 1981

ACCC Annual Meeting To Study Organizing Community Care

January 26, 1979

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007